Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia
Ivanova, T.N.; Poliakova, E.D.; Olfer'ev, A.M.; Perova, N.V.
Biulleten' Eksperimental'noi Biologii i Meditsiny 125(5): 569-573
1998
ISSN/ISBN: 0365-9615 PMID: 9644562 Document Number: 488142
Document emailed within 1 workday
Related Documents
Poliakova, E.D.; Ivanova, T.N.; Nikulina, S.E.; Metel'skaia, V.A.; Olfer'ev, A.M.; Shcherbakova, I.A.; Akhmedzhanov, N.M.; Perova, N.V. 1994: Changes in the rate of cholesterol synthesis in lymphocytes, and blood lipid and lipoprotein levels in patients with ischemic heart disease and hypercholesterolemia during treatment with lovastatin and obsidan Biulleten' Eksperimental'noi Biologii i Meditsiny 117(3): 248-251Okopień, B.ła.; Cwalina, Łu.; Haberka, M.; Kowalski, J.; Zieliński, M.; Szwed, Z.; Kalina, Z.; Herman, Z.S. 2002: Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(78): 465-469
Vasil'chenko, E.M.; Beĭko, V.A.; Tymchishin, P.N.; Karpov, R.S. 1989: Changes in the rosette-forming capacity of peripheral blood lymphocytes in patients with ischemic heart disease after administration of atherogenic lipoproteins Kardiologiia 29(2): 53-56
Vasil'chenko, E.M.; Beĭko, V.A.; Karpov, R.S.; Kanskaia, N.V. 1989: Characteristics of the action of modified atherogenic-class lipoproteins on the functional activity of peripheral blood lymphocytes in patients with ischemic heart disease Terapevticheskii Arkhiv 61(9): 56-59
Márk, L.ás.ó; Márki-Zay, J.án.; Orosz, I.án.; Kondacs, A.ás.; Erdei, F.; Katona, A.ás. 2003: Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease Orvosi Hetilap 144(16): 765-768
Shpak, B.I.; Neĭko, E.M.; Debenklo, M.V.; Lazho, A.S.; Duma, Z.V. 1988: Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease Vrachebnoe Delo 3: 34-36
Kalinina, A.M.; Chazova, L.V.; Perova, N.V.; Pavlova, L.I.; Shchepkin, V.V. 1993: An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol Terapevticheskii Arkhiv 65(4): 27-32
Shteĭngardt, I.N.; Tiukalova, L.I.; Markov, V.A.; Kun, V.I.; Tsymbaliuk, V.P. 1983: Effect of various drugs on peripheral hemodynamics in left-ventricular insufficiency in patients with chronic ischemic heart disease Kardiologiia 23(3): 91-95
Nitta, T.; Okumura, S.; Nakano, M. 1985: Synergistic effect of concanavalin a and Bu-WSA on DNA synthesis in human peripheral blood lymphocytes Journal of Immunology 134(2): 808-814
Vasil'ev, A.V.; Bil'dinov, O.A.; Lepilin, M.G. 1990: Effect of nitrous oxide on myocardial activity and blood supply in patients with ischemic heart disease Anesteziologiia i Reanimatologiia 2: 7-9
Gaponova, M.V.; Shakalis, D.A.; Maliutina, S.K. 1988: Cholesterol esterase activity of blood monocytes and the main risk factors of ischemic heart disease in men aged 20-59 Terapevticheskii Arkhiv 60(9): 102-106
Lebshtein, A.K.; Hanafi, A.; Ezzat, W.M. 1976: The prevalence of hypertension, diabetes and ischemic heart disease, their blood lipids and cholesterol in different social groups in Egypt Journal of the Egyptian Public Health Association 51(3): 127-137
Lankin, V.Z.; Revenko, V.M.; Lupanov, V.P.; Tikhaze, A.K.; Liakishev, A.A.; Kukharchuk, V.V. 1993: The effect of long-term probucol intake on the lipoprotein cholesterol content and glutathione peroxidase activity in the blood of patients with coronary arteriosclerosis and hyperlipidemia Kardiologiia 33(9): 41
Dudaev, V.A.; Diukov, I.V.; Borodkin, V.V. 1988: Effect of physical training on the clinical course and the status of blood coagulation hemostasis in patients with ischemic heart disease Kardiologiia 28(11): 22-26
Skopińska-Rózewska, E.; Liszewska-Pfejfert, D.; Małkowska-Zwierz, W.; Pawińska, M.; Polakowski, I.J.; Wróblewski, T. 1989: Subpopulations of t lymphocytes in patients with ischemic heart disease Polski Tygodnik Lekarski 44(6): 147-149
Wakabayashi, Y.; Shiokawa, Y.; Takaku, F. 1979: Effect of folic acid on the DNA synthesis in peripheral lymphocytes from patients with liver cirrhosis Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(3): 341-346
Kovalenko, V.M.; Shunkova, E.I.; Gol'dberg, G.A.; Karagaeva, L.G.; Shlafer, I.D.; Epifantseva, N.N. 1991: The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise Kardiologiia 31(9): 42-44
Broncel, M.; Cieślak, D.; Koter-Michalak, M.; Duchnowicz, P.; Mackiewicz, K.; Chojnowska-Jezierska, J. 2006: The anti-inflammatory and antioxidants effects of micronized fenofibrate in patients with visceral obesity and dyslipidemia Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(119): 547-550
Parfenova, N.S.; Petrova-Maslakova, L.G.; Kuznetsov, A.S.; Ioffe, D.V.; Alksnis, E.G. 1988: Impairment of cholesterol-acceptor function of high density lipoproteins in patients with ischemic heart disease Voprosy Meditsinskoi Khimii 34(2): 42-46
Vodoevich, V.P.; Buko, V.U. 1986: Effect of the B-group vitamin complex on the blood content of saturated and unsaturated fatty acids in patients with ischemic heart disease and hypertension Voprosy Pitaniia 2: 9-11